Clinical trials referenced in this document:
Documents that mention this clinical trial
Effect of Orally Administered Semaglutide Versus Dulaglutide on Diabetes-Related Quality of Life in Japanese Patients with Type 2 Diabetes: The PIONEER 10 Randomized, Active-Controlled Trial
https://doi.org/10.1007/s13300-020-00985-w
Funding for this research was provided by:
Novo Nordisk Pharma Ltd
Article History
Received: 16 November 2020
Accepted: 11 December 2020
First Online: 18 January 2021